This clinical research study is aimed at assessing an investigational drug called fasinumab. The primary objective of this study is to evaluate the efficacy and safety of investigational drug, fasinumab compared to placebo (an inactive substance) and non-steroidal anti-inflammatory drugs (NSAIDs) celecoxib and diclofenac when administered for up to 24 weeks in people with pain due to OA of the knee or hip.

Find out if you pre-qualify: